Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Stress Prevention and Stress Management Techniques IV

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...

Binge Eating Disorders

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Treatment preferences for comorbid obesity and obstructive sleep apnea (PRO-CON OSA) survey: Patient and provider preferences for CPAP and/or tirzepatide.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026

Same author

Treatment preferences for comorbid obesity and obstructive sleep apnea (PRO-CON OSA) survey: Patient and provider preferences for CPAP and/or tirzepatide.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026

Same author

Treatment Preferences For Comorbid Obesity and Obstructive Sleep Apnea (PRO-CON OSA) Survey: Patient and Provider Preferences for CPAP and/or Tirzepatide.

medRxiv : the preprint server for health sciences·2025

Same author

Calling guidance evidence-based when it is not is against the ethos of science.

The American journal of clinical nutrition·2025

Same author

Development of a core patient-centred outcome set for adults living with obesity: a modified delphi-based international consensus.

EClinicalMedicine·2025

Same author

Exploring the Role of Internalized Weight Bias as a Metric of Cumulative Social Disadvantage Among People With Obesity or Overweight: Insights From the OBSERVE Study.

Obesity science & practice·2025

Search research articles

Related Experiment Video

Updated: Mar 17, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Obesity and government.

Scott Kahan¹, Tracy Zvenyach

¹aJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland bGeorge Washington University School of Medicine, Washington, DC cUniversity of Maryland School of Nursing, Baltimore, Maryland dGeorgetown University School of Nursing and Health Studies, Washington, DC, USA.

Current Opinion in Endocrinology, Diabetes, and Obesity

|July 29, 2016

Summary

Government initiatives in the USA address obesity through food and nutrition policies, focusing on prevention. However, access to evidence-based obesity care requires further government development.

More Related Videos

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Published on: June 21, 2019

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Related Experiment Videos

Last Updated: Mar 17, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Published on: June 21, 2019

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Area of Science:

Public Health
Nutrition Policy
Obesity Prevention

Background:

Obesity prevalence and severity continue to rise despite significant efforts.
Government interventions are crucial for public health strategies against obesity.

Purpose of the Study:

To review leading government-supported food and nutrition interventions and policies in the USA for obesity prevention and management.
To identify areas where government involvement in obesity interventions and policies needs further development.

Main Methods:

Literature review of government-supported food and nutrition interventions and policies.
Analysis of the government's role in obesity prevention and clinical care.

Main Results:

Government focus has been on surveillance, education, food subsidies, zoning, school programs, dietary guidelines, labeling, and marketing/pricing policies.
Government involvement in providing access to evidence-based obesity care is less developed.

Conclusions:

The escalating obesity epidemic necessitates a comprehensive approach.
Government should expand evidence-based interventions and policies for both obesity prevention and clinical care.